Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Non-Current Liabilities (2016 - 2025)

Palisade Bio has reported Other Non-Current Liabilities over the past 14 years, most recently at $62000.0 for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $62000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $62000.0 for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities was $62000.0 for Q4 2025 at Palisade Bio, down from $283000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $20.5 million in Q2 2021 and troughed at $2000.0 in Q2 2023.
  • The 5-year median for Other Non-Current Liabilities is $116601.0 (2021), against an average of $2.0 million.
  • Year-over-year, Other Non-Current Liabilities soared 32677.09% in 2021 and then plummeted 99.57% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.7 million in 2021, then plummeted by 85.21% to $392000.0 in 2022, then plummeted by 84.44% to $61000.0 in 2023, then decreased by 26.23% to $45000.0 in 2024, then soared by 37.78% to $62000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Non-Current Liabilities are $62000.0 (Q4 2025), $283000.0 (Q3 2025), and $2000.0 (Q2 2025).